Lisdexamfetamine

Results: 41



#Item
1VYVANSE® [Vī’ - văns] MEDICATION GUIDE (lisdexamfetamine dimesylate) CII Capsules What is the most important information I should know about

VYVANSE® [Vī’ - văns] MEDICATION GUIDE (lisdexamfetamine dimesylate) CII Capsules What is the most important information I should know about

Add to Reading List

Source URL: medguide.shirecontent.com

- Date: 2016-10-20 10:37:57
    2prilTreatments for Attention Deficit Hyperactivity Disorder in Adults  FINAL PHARMACOEPIDEMIOLOGY REPORT

    prilTreatments for Attention Deficit Hyperactivity Disorder in Adults FINAL PHARMACOEPIDEMIOLOGY REPORT

    Add to Reading List

    Source URL: odprn.ca

    Language: English - Date: 2015-12-22 13:41:24
    3prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of

    prilFINAL CONSOLIDATED REPORT DecemberDrugs Used in the Management of

    Add to Reading List

    Source URL: odprn.ca

    Language: English - Date: 2015-12-21 11:29:00
    4Microsoft Word - VYVANSE.Product Monographdoc

    Microsoft Word - VYVANSE.Product Monographdoc

    Add to Reading List

    Source URL: www.shirecanada.com

    Language: English - Date: 2016-03-02 15:52:19
    5Patient Assistance Program    Shire Pharma Canada ULC (“Shire”) developed the VYVANSE Patient Assistance Program (the “Program”) for Canadian  patients requiring support by covering for t

    Patient Assistance Program    Shire Pharma Canada ULC (“Shire”) developed the VYVANSE Patient Assistance Program (the “Program”) for Canadian  patients requiring support by covering for t

    Add to Reading List

    Source URL: www.shirecanada.com

    Language: English - Date: 2016-03-02 15:52:19
    6Microsoft Word - VYVANSE.Product Monographdoc

    Microsoft Word - VYVANSE.Product Monographdoc

    Add to Reading List

    Source URL: www.shirecanada.com

    Language: English - Date: 2016-03-02 15:52:19
    7Euphoriants / Health / Psychiatry / Childhood psychiatric disorders / Nootropics / Lisdexamfetamine / Methylphenidate / Attention deficit hyperactivity disorder / Dextroamphetamine / Medicine / Attention-deficit hyperactivity disorder / Amphetamines

    7.3 LISDEXAMFETAMINE DIMESILATE, capsules, 30 mg, 50 mg & 70 mg, Vyvanse®, Shire Australia Pty Ltd Purpose of Application The resubmission requested an Authority Required listing for lisdexamfetamine (LDX) on the PBS f

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2015-04-22 23:39:46
    8Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

    Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that

    Add to Reading List

    Source URL: www.scottishmedicines.org.uk

    Language: English
    9Microsoft Word - Shire- 7-3 lisdexamfetaminePSD  final.docx

    Microsoft Word - Shire- 7-3 lisdexamfetaminePSD final.docx

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2015-04-22 23:39:46
    10HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYVANSE safely and effectively. See full prescribing information for VYVANSE. VYVANSE ® (lisdexamfetamine dimesylat

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VYVANSE safely and effectively. See full prescribing information for VYVANSE. VYVANSE ® (lisdexamfetamine dimesylat

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2015-02-05 09:50:28